OUTCOME OF BOARD MEETING
NIPPOBATRY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.1 pts less than Nifty Microcap 250 and 8.2 pts less than its Household Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indo National Limited reported a significant loss for FY2026, swinging from a profit of Rs. 101.39 Lakhs (standalone) last year to a loss of Rs. 1,039.71 Lakhs. Consolidated loss was even larger at Rs. 2,669.20 Lakhs versus profit of Rs. 12,194.61 Lakhs in the previous year. Revenue declined marginally by about 1.5% to Rs. 45,101 Lakhs (standalone). The company faced increased costs, with employee benefits and finance costs rising. A new labour code liability of Rs. 86 Lakhs was recognized. The Board recommended a dividend of Rs. 3.75 per share (75%). Statutory auditors G Balu & Associates issued an unmodified (clean) opinion. During the year, the company acquired 54.79% stake in Medcuore Medical Solutions and invested Rs. 850 Lakhs in Axial Aero via CCPS. The NCLT approved amalgamation of Helios Strategic Systems (wholly-owned subsidiary) effective April 2, 2026.
The company swung from profit to substantial loss, which is a major red flag for investors. Despite the loss, the Board recommended a dividend showing confidence, but shareholders should monitor the company's turnaround plan given the significant decline in profitability and the pending Rs. 4,226 Lakhs CCI penalty case.